Blog Posts
Ghana: Vectron T500 innovated to support malaria resistance management deployed
A new Indoor Residual Spray (IRS) product for malaria control has been deployed in Ghana to support the country’s malaria elimination efforts. The innovation, Vectron T500, produced by Mitsui Chemicals Crop and Life Solutions, is a non-repellent, odourless and stainless formulation with low toxicity to mammals, and has a different […]
Shipment of newest malaria vaccine, R21, to Central African Republic marks latest milestone for child survival
UNICEF delivered over 43 000 doses of the R21/Matrix-M malaria vaccine by air to Bangui, Central African Republic, today, with more than 120 000 doses to follow in the next days. It is the first country to receive the R21 malaria vaccine for use in routine childhood immunization, marking another step forward […]
Authorities in Uganda ramp up campaign on yellow fever amid vaccine hesitancy
Uganda launched a mass vaccination campaign in April against the mosquito-borne disease, yellow fever. They hoped to reach millions of people but vaccine hesitancy has left hundreds of unused doses in hospitals across the country. There is no specific treatment for the potentially deadly yellow fever virus. There is, however, […]
FDA mollify concerns over AstraZeneca Covid-19 vaccine safety in Ghana
The Food and Drugs Authority (FDA) has reaffirmed its commitment to monitoring the safety of all vaccines used in Ghana, including COVID-19 vaccines. The FDA says that the Emergency Use Authorization (EUA) for AstraZeneca vaccines which expired in May 2023, coincided with the World Health Organization listing COVID-19 as no […]
Mapping malaria in Africa: climate change study predicts where mosquitoes will breed in future
The relationship between climate and malaria transmission is complex and has been the subject of intense study for some three decades. Mosquito vector populations sufficient to maintain malaria transmission occur within a particular range of temperatures and humidity that are suitable for their survival and breeding. The parasite also needs […]
New dengue vaccine TAK-003 gains WHO prequalification for high-burden areas
A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue. WHO […]
